Anna Pruitt
Sports Medicine · Winder, GANPI 1578085395
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 327 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 53 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,063, more than ten times the $42 reported in 2020.
Across 327 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$664
- Harmony Biosciences LLC$423
- EMD Serono, Inc.$382
- TG Therapeutics, Inc.$361
- Teva Pharmaceuticals USA, Inc.$353
- AbbVie$328
- plus $4K from 47 others
What the payments were for
- Food & beverage$5,88897%
- Education$1563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRIUMVI$245
How this compares
$6,044 in reported general payments places this provider in the 70th percentile of 168 sports medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 25 | $319,197 |
| UbrelvyUbrogepant | 71 | $72,344 |
| QuliptaAtogepant | 48 | $71,656 |
| Nurtec OdtRimegepant Sulfate | 47 | $70,613 |
| Emgality PenGalcanezumab-Gnlm | 84 | $67,404 |
| CopaxoneGlatiramer Acetate | 11 | $61,495 |
| Memantine Hcl | 412 | $9,015 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 310 | $8,078 |
| RivastigmineRivastigmine Tartrate | 94 | $6,228 |
| Gabapentin | 433 | $6,094 |
| Levetiracetam | 152 | $5,956 |
| Divalproex Sodium ErDivalproex Sodium | 104 | $4,552 |
| Carbamazepine ErCarbamazepine | 38 | $2,942 |
| Pyridostigmine Bromide | 43 | $2,924 |
| Levetiracetam ErLevetiracetam | 48 | $2,469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $47 | $319,19725 claims |
| AbbVieUbrelvy, Qulipta | $328 | $144,000119 claims |
| PfizerNurtec Odt | $273 | $70,61347 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $353 | $61,49511 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide, Mycophenolate Mofetil | $69 | $4,42561 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 168 sports medicine providers in Georgia.
Other sports medicine in Winder
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Robert O'ConnellCarrollton$69K
- Elan GolanSnellville$57K
- Taylor PolanderJesup$48K
- Anthony CantrellCanton$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.